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ABSTRACT
Nonadherence to medical regimens is a critical behavioral threat to the health 
of HIV-infected individuals. Patients cannot benefit from increasingly efficacious 
treatments for HIV/AIDs unless they adhere to them. Consistent medical care plays 
a central role in prolonging life and enhancing quality of life for these individuals. It 
is therefore essential to understand why many patients do not return reliably for 
medical services. However, little research has focused on the development of 
empirically based models of HIV-related nonadherence. Thus, the primary purpose 
of the present study was to identify factors predictive of HIV-related nonadherence to 
medical appointments. Demographic, medical care, and psychosocial factors were 
identifîed that prospectively predicted percentage of scheduled H IV clinic 
appointments no-showed by outpatients. The results of this study indicated that 
greater nonadherence to ouq>atient appointments was associated with younger age, 
minority background, less severe illness, and lower perceived social support. 
Individuals from minority backgrounds and younger age groups were found to have 
higher rates of nonadherence to HIV treatment demands. Nonadherence was also 
demonstrated to be problematic early in the disease course. From the perspective of 
potential psychosocial interventions, it was particularly interesting that higher levels 
of perceived social support were associated with less outpatient visit nonadherence. 
Practical and theoretical implications of these findings are discussed in light of recent 
medical advances.
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INTRODUCTION
Since the Grst cases were identified in 1981, AIDS has been fearfully 
heralded as the disease of the century and a societal problem of paramount 
importance for our time. As we approach the twenty-first century, HTV and AIDS 
have already reached pandemic proportions (Anderson & May, 1992; Mann, 
Tarantola, &  Netter, 1992; Mann & Tarantola, 1996). The major risk Actors for 
HIV infection are behaviors which can be changed. Consequently, the emphasis of 
much psychological research is on the prevention of high risk sexual and drug- 
injecting behaviors (Kelly, 1995). Despite attempts to mobilize public health 
resources, prevention efforts have not stopped HIV from reaching the status of a 
global epidemic. While HIV risk behavior reduction continues to be a pressing issue 
amenable to behavioral study and intervention, the increasingly high prevalence of 
HIV also points to the need for salient investigations of health behaviors among those 
already infected with HIV.
Nonadherence to medical regimens is one of the most pervasive and 
problematic behavioral threats to the health of chronically ill individuals (Dunbar- 
Jacob, Burke, & Puczynski, 1995). Patients cannot benefit optimally from medical 
care if they do not adhere to their recommended medical treatments. Although the 
progression from HIV infection to AIDS is irreversible, beneficial medical 
interventions are currently available. Medical management of this chronic, life- 
threatening syndrome entails regular medical monitoring and ongoing preventive and 
curative interventions. Consistent medical care plays a central role in prolonging
I
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life, improving general health, and enhancing overall quality of life among 
individuals at each phase of the HIV/AIDS spectrum. Nonadherence to HIV-related 
medical regimens may therefore pose a very serious health problem (Chesney & 
Folkman, 1994). Unfortunately, few empirical studies have sought to investigate the 
magnitude of this problem or to explore biopsychosocial factors which may 
contribute to medical nonadherence among individuals with HIV/AIDS. The 
deleterious effects of medical nonadherence on the health and well-being of HIV- 
infected patients might be mitigated by appropriate intervention. Current knowledge 
regarding psychosocial and medical care factors most relevant to HIV-related 
nonadherence, however, is not sufficiently well developed to serve as a firm base for 
corrective measures. Thus, research to address the issue of nonadherence among this 
growing medical population is clearly needed.
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HIV
To fully appreciate the need for addressing treatment nonadherence among the 
HIV-infected, a broad understanding of HIV is essential. The socio-culturai, 
biomedical, and psychosocial aspects of HIV infection and its progression to AIDS 
will therefore be reviewed.
Scope of the Epidemic
Worldwide, as many as 20.3 million adults were estimated to be HIV-infected 
in 1996 and by the end of this century the number is likely to reach 60-70 million 
(Mann &  Tarantola, 1996; World Health Organization, 1995). The transmission of 
human immunodeficiency virus (H IV) and the prevalence of acquired 
immunodeficiency syndrome (AIDS) have continued to expand, and now impact 
nearly every country in the world (Mann & Tarantola, 1996). In the United States 
alone, more than half a million cases of AIDS had been reported to the Centers for 
Disease Control by the end of 1996 (CDC, 1997). AIDS has been the leading cause 
of death among American men aged 25-44 since 1992 (CDC, 1993). By 1995,
AIDS caused 19% of all American deaths in the 25-44 age range (CDC, 1997). The 
scope of the HIV-AIDS epidemic can best be conceptualized as a conglomerate of 
subepidemics affecting an increasingly broad array of high risk populations 
(Kalichman, 1995). After the AIDS surveillance case definition (i.e., the set of 
diagnostic criteria disseminated by the CDC and used to track the epidemic) was 
expanded in 1993, the most rapidly growing subpopulations of AIDS cases were 
among adolescents, women, racial and ethnic minorities, and individuals infected
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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through drug injection or heterosexual contact (CDC, 1995b; CDC, 1997; Karon, 
Rosenberg, McQuillan, Khare, Gwinn, & Petersen, 1996).
HIV and AIDS have a devastating impact on an increasingly broad 
sociodemographic range of individuals. The rate of HTV infection among any given 
segment of the population is determined by the likelihood of the virus being 
transmitted to uninfected individuals from those who are already infected. The 
principle routes of HIV infection among adults are via fluid-exchanging sexual 
activi^ and contact with infected blood, either by transfusion or contaminated 
injection equipment (Glasner & Kaslow, 1990). The virus is transmitted most 
efficiently through the behaviors of anal intercourse, vaginal intercourse, and by 
sharing drug-injecdon needles. Thus, individuals who engage in relatively high rates 
of these behaviors and/or with a wider network of potentially seropositive partners 
are at highest risk for HIV infection. The earliest subpopulations infected in the 
United States were male homosexuals and hemophiliacs who received blood product 
transfusions from multiple donors. Injection drug-users who share needles 
frequently and heterosexuals who engage in unprotected vaginal or anal intercourse 
with multiple partners are at the highest risk for infection among these 
subpopulations. Multiple risk factors and cross-modal HIV transmission (i.e., drug- 
injectors infecting sexual parmers) are increasingly common (CDC, 1995a). 
Currently, heterosexual contact accounts for the majority of AIDS cases worldwide 
and homosexual contact accounts for the largest proportion of AIDS cases in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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U.S., with infection rates continuing to grow across diverse segments of American 
society (CDC, 1997; Kalichman, 1995; Karon et al., 1996).
Pathogenesis and Clinical Course
Viral characteristics.
HIV is a retrovirus. Retroviruses have a genetic core of RNA which is 
converted into viral DMA and integrated with the DNA of infected host cells. This 
means that a retrovirus such as HIV is able to "hide” safely within a host cell for 
long periods of time and is capable of using the cell's resources to replicate itself as 
a free virus (Fauci, 1988). HTV has the highest binding affinity for cells with 
antigen receptor cites classified as cluster determinant 4 (CD4) surface molecules 
(Fauci, 1988). Thus, HIV selectively integrates and destroys CD4  expressing cells 
such as T-helper lymphocytes. T-helper cells, the primary pathogenic target of HIV, 
play a crucial role in immune functioning. CD4  T-helper cells serve to coordinate 
immune system responses by stimulating the B lymphocytes responsible for 
producing antigens to combat foreign agents in the body. Depletion of T-helper 
lymphocytes is the immunologic result of HIV infection that is primarily responsible 
for the pervasive immunosuppression characteristic of AIDS (Fauci, 1988).
In addition to the direct effects of HIV on T-helper cells, the virus has other 
indirect immunocompromising effects. Of particular importance, T-helper cells 
mediate the activity of natural killer cells and T-suppressor cells. Thus, their 
destruction has a deleterious efiect on the abili^ of the immune system to fight 
infection-causing and tumor-causing agents or to modulate immune responses when
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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these threats diminish (Devita, Heilman, &  Rosenberg, 1985; Fauci, 1988). Also, 
HIV either binds to, or is "swallowed” by, CD4  expressing monocyte macrophages. 
This is important because infected macrophages are prevented from acting as 
phagocytes which engulf and kill microorganisms, and because H IV  can be "safely" 
transported to the brain, lungs, and other parts of the body once within a macrophage 
(Rosenberg & Fauci, 1991). Thus, HIV impairs immune functioning both directly 
and indirectly, leaving infected individuals vulnerable to attack from a number of 
opportimistic infectious diseases that would otherwise be suppressed by the immune 
system.
Stages of disease progression.
HIV infection begins a chronic, fluctuating disease course that eventually ends 
in AIDS-related illness and death (Schecter et al., 1990). Shortly after HIV  
transmission, an acute period of retroviral infection may manifest itself in some 
individuals as a 1-2 week mononucleosis-like syndrome (Tindall et al., 1992). HIV 
infection then follows a variable clinical course characterized by: (a) a lengthy 
"silent" or asymptomatic period, (b) an immunocompromised or symptomatic phase, 
and (c) and an advanced stage in which AIDS-related illnesses are likely to be 
manifested. The progression of H IV to AIDS has been classified in various ways as 
medical knowledge has increased (CDC, 1987). A useful system for classifying the 
HIV/AIDS spectrum is m describe stages of disease progression on the basis of T- 
helper cell counts (Bartlett, 1993; Clement & Hollander, 1992). Individuals with T- 
cell counts higher than 500 cells per mm̂  may be considered asymptomatic, while
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people with T-cell counts from 200 to 500 cells/mm  ̂can be described as 
immunocompromised. T-helper lymphocyte counts below 200 cells/mm  ̂are within 
the AIDS diagnosis range (CDC, 1992), with AIDS-related illnesses being most 
prevalent when T-cell counts fall below 100 cells/mm .̂ Although T-cell counts are 
considered a fairly reliable marker of disease progression, the rate of decline 
(typically a reduction of 50-100 cells/mm  ̂per year) may differ markedly across 
individuals, with the time from infection to AIDS varying from I to 15 years 
(Kalichman, 1995).
Current CDC AIDS case definition criteria include evidence of either immune 
system deterioration following HIV infection (T-cell counts below 200 cells/mm  ̂) or 
the presence of any of 25 AIDS-defining conditions (CDC, 1992). While most 
AIDS-related complications are due to the effects of immunosuppression (i.e.. 
Candidiasis infection, pneumocystis carinii pneumonia (PCP), mycobacterium 
tuberculosis, invasive cervical cancer, Kaposi's sarcoma), some are attributed to 
direct HIV infection of various organs and systems (e.g., lymph nodes, lungs, brain). 
Despite the variable patterns of AIDS-related illnesses across individuals, each case 
of AIDS has one commonalî . Infections or malignancies that would normally be 
rare, or even innocuous, become life-threatening in the free of a severely depleted 
immune system.
Medical treatment and proohvlaxis.
Given the natural history of HIV and the current status of medical 
intervention technology, the primary aims of medical management are (a) to slow the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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loss of T-helper lymphocytes, (b) to prevent and treat opportunistic infections, and 
(c) to prevent the growth of malignancies. Rapid advances in the medical 
management of HIV have led to increased life expectancies for today's HIV-infected 
patients. For example, the most recent reports from the Centers for Disease Control 
and Prevention attribute the first ever decline in U.S. AIDS-related deaths in 1996 to 
the life-prolonging effects of antiretroviral and anti-infective medications that were 
standard clinical care by the 1990's (CDC, 1997). Current standards of care dictate 
that medical management should begin immediately after HIV diagnosis.
Frequent monitoring of immune status is recommended. Regular lymphocyte 
counts and measures of plasma viral load (i.e., blood levels of HIV RNA) serve as 
markers of disease progression and provide a partial basis for deciding when to begin 
pharmacological interventions designed to slow this progression (Carpenter et al., 
1996). Initiation of antiretroviral treatments such as zidovudine (AZT) or 
combination therapies are generally suggested when CD« counts fall below 500 
cells/mm  ̂ (Marchland, Klein, & Struble, 1996; U.S. Department of Health and 
Human Services, 1994). Nucleoside and protease inhibitor combination therapies act 
to suppress viral replication of HIV, and thus serve to slow T-cell decline and to 
minimize opportunistic diseases (Bartlett, 1993; Carpenter et al., 1996).
To prevent opportunistic infections and malignancies, a number of routine 
medical examinations are also recommended (U.S. Department of Health and 
Human Services, 1994). Oral and eye examinations are required to detect mouth and 
ocular lesions indicative of Kaposi's sarcoma or opportunistic infections such as
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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cytomegalovirus (CMV) retinitis. For women, regular gynecologic examinations 
are suggested (e.g., for candidiasis and cervical cancer detection). Other HIV- 
related illnesses requiring routine medical screening include mycobacterium 
tuberculosis and syphilis. In addition to the recommended medical screening 
protocols, another important component of medical management for H IV involves the 
prophylactic pharmacologic treatment of the most common opportunistic infections 
(U.S. Department of Health and Human Services, 1994). For example, prophylactic 
treatments including aerosolized pentamidine and bactrim have significantly reduced 
rates of AIDS-related PCP (Osmond, Charlebois, Lang, Shiboski, &  Moss, 1994).
In summary, although the progression to acquired immunodeficiency 
syndrome cannot yet be reversed, routine medical care is essential for prolonging 
life, improving general health, and alleviating suffering among individuals at each 
phase of the HIV/AIDS spectrum. Optimal management of this chronic syndrome 
entails consistent medical monitoring and intervention.
Psvchosocial Aspects of HIV
There are many characteristics of HIV infection which may impact 
psychosocial adjustment. An incurable prognosis and a chronic, fluctuating disease 
course combine with social stigmatization to pose complex challenges to the coping 
resources of infected individuals. The course of adjustment may include distress 
reactions (i.e., denial, depression, hopelessness, anxiety, somatization, anger, guilt) 
as well as efforts to reframe HIV-related experiences and to regain emotional 
equilibrium (i.e., searches for meaning, control, and support; renewed self-efficacy.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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optimism and spiritualiQr) (Borden, 1991; Holland & Tross, 1985; Kalichman, 1995; 
Kalichman & Sikkema, 1994; Kelly & St. Lawrence, 1988; Ostrow et al., 1989; 
Pakenham, Dadds, & Terry, 1994; Siegel & Krauss, 1991). Psychosocial 
functioning may vary across phases of the disease (Kessler et al., 1988) and to some 
extent across different demographic groups (Ostrow et al., 1991).
Psychological reactions to HIV often tend to model the fluctuating patterns of 
the disease process itself (Chesney &  Folkman, 1994; Kalichman, 1995). When 
individuals initially learn of their H IV seropositive status they may react with shock, 
disbelief, denial, grief, depression, hopelessness, guilt, anger, or fear (Cleary et al., 
1993; Chesney & Folkman, 1994; Ostrow et al., 1989). This initial distress often 
fades during the asymptomatic phase of infection and reemerges with the onset of 
HIV-related symptoms (Blaney et al., 1990; Rabkin et al., 1990; Kelly et al., 1993). 
Thus, adjustment difficulties are likely to reoccur just as immimologic functioning 
begins to decline noticeably and to necessitate increased medical monitoring and 
management. New physical symptoms or information about "benchmark" declines 
in CD4  coimts (i.e., dropping below cell counts of 500 or 200) may serve to trigger 
exacerbations in psychological distress (Ostrow et al., 1989). As the disease 
progresses to AIDS, patients gradually experience an inevitable series of losses 
threatening every aspect of their quali^ of life, from leisure and work activities to 
physical well-being and mental health (Chesney &  Folkman, 1994; Kelly &  St. 
Lawrence, 1988). The reduction in energy, loss of weight and attractiveness, 
declining cognitive and physical abilities, and general curtailment of activities which
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
H
can accompany AIDS-related diseases may be associated with feelings of acceptance 
or even hopelessness (Reed, Kemeny, Taylor, Wang, & Visscher, 1994; Rabkin et 
al., 1990). The parallel phases of psychological and physical symptoms outlined 
thus far, presuppose diagnostic notification early in the infection process. The 
psychological impact may be condensed, and potentially more devastating, if 
individuals are already sick with an AIDS-related disease when they learn of their 
status (Kalichman, 1995).
Depression is perhaps the most pervasive, and certainly the most commonly 
studied, distress reaction among HIV-infected individuals (Kalichman & Sikkema, 
1994). Although not everyone responds to HIV with clinically significant distress 
(Perry, Jacobson, & Fishman, 1990; Williams et al., 1991) the most prevalent 
psychiatric diagnosis among HIV populations is adjustment disorder with depressed, 
anxious, or mixed features (O’Dowd, Natali, Orr, &  McKegney, 1991; Chuang, 
Jason, Pajurkova, & G ill, 1992). Many investigators have found that HIV-infected 
individuals from a varieQr of backgrounds (i.e., drawn from homosexual, minority, 
hemophiliac, military, blood donor, and heterogenous samples) report clinically 
significant levels of depression (Atkinson et al., 1988; Bernstein et al., 1993; 
Cochran & Mays, 1994; Dew, Ragni, & Nimorwicz, 1990; Kelly et al., 1993; 
Rabkin et al., 1991; McClure et al., 1996; Miller &  Riccio, 1990). However, there 
are methodological issues which limit the validity of many HIV depression studies 
(Kalichman & Sikkema, 1994). Most importantly, measurement of depression 
among infected individuals may be confounded by overlapping physical symptoms of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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HIV and medication side effects such as Wgue, anorexia/weight loss, impaired 
concentration, or night sweats/insomnia (Belkin, Fleishman, Stein, Piette, & Mor, 
1992; Drebing et ai., 1994). Confounds can be minimized by removing HIV-related 
somatic symptoms from depression measures either statistically (Kelly et al., 1993) 
or via omission (Burrack, Barrett, Stall, Chesney, Ekstrand, & Coates, 1993). Such 
procedures leave intact key affective and cognitive components of depression, such as 
hopelessness.
Hopelessness is arguably one of the most salient aspects of depressive 
reactions among those infected with HIV (Kalichman, I99S). Hopelessness (i.e., 
severe pessimism about the future) may be an especially relevant component of 
HIV/AlDS-related distress because of the terminal prognosis, uncertain disease 
course, and social isolation associated with the disease (Kalichman, 1995; Rabkin, 
Williams, Neugebauer, Remien, & Goetz, 1990). In Act, hopelessness was found to 
be significantly elevated among HIV-positive individuals as compared to both cancer 
patients (Kelly, Dunne, & Raphael, 1991) and seronegative hemophiliacs (Catalan, 
Klimes, Bond, Day, Garrod, & Rizza, 1992). Unlike many indices of depression 
that overlap with HIV-related physical symptoms, measures of hopelessness tap 
primarily cognitive and affective domains of distress. For example, beyond the 
contributions of HIV status and symptom frequency, a relationship between 
hopelessness and depression has been demonstrated (Rabkin et al., 1990). Among 
HIV-infected gay men in a major epicenter, Rabkin and colleagues (1990) found that 
24% of their sample obtained moderate to severe elevations on the Beck
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Hopelessness Scale. Another study of hopelessness among HIV-positive 
hemophiliacs yielded similar results (Miller and Riccio, 1990). In general, 
investigations of psychosocial functioning have found hopelessness positively related 
to psychological morbidity and negatively related to overall psychological adjustment 
among HIV-positive individuals (Kelly, Dunne, & Raphael, 1991; Catalan et al., 
1992). Greater levels of hopelessness have also been associated with decreased 
social support (Rabkin et al., 1990; Zich & Temoshok, 1987).
Attempts to manage the demands associated with HIV can lead to positive and 
adaptive responses as well as to emotional distress. For example, interview data 
indicates that many gay men report positive changes associated with HIV infection, 
including reprioritizing life goals, increasing commitment to health-related behaviors, 
and strengthening social relationships (Borden, 1991). More empirical evidence also 
links social support and coping to positive adjustment among those infected with 
HFV. A recent study suggested that social support was relatively more strongly 
associated with disease status and social adjustment to illness, while coping strategies 
involving optimism, control, action, and interpersonal coping were associated with 
higher levels of both illness-related and global psychological health (Pakenham, 
Dadds, &  Terry, 1994). Another recent investigation suggested that the use of 
spiritual coping may potentially broaden sources of support and improve positive 
adjustment to HIV (Somlai et al., 1996). Optimistic beliefs about the future 
consequences of HIV, even when unrealistic, have also been associated with better
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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psychological adjustment, with more active coping, and with maintenance of health 
behaviors (Taylor e ta l., 1992).
Clearly, the psychosocial changes experienced by HIV-infected patients 
interact with other dimensions of their qualî  of life and with health-related 
behaviors. For example, Siegel and Krauss (1991) conceptualized adjustment to HIV 
in terms of five challenges which, according to several coping theorists (Cohen & 
Lazarus, 1979; Miller, 1983) are faced by all chronically ill individuals. These 
essential adaptive tasks include; (a) decreasing threatening conditions and increasing 
positive outcomes [complying with prescribed regimens, altering lifestyles, acquiring 
self-care skills], (b) dealing with negative events and expectations [combatting 
stigma, confronting the inevitability of death, managing physical discomfort, grieving 
over losses], (c) maintaining self-esteem [regaining a sense of control and normalcy, 
maintaining a positive self-image], (d) stabilizing emotions [maintaining hope], and 
(e) maintaining positive social relationships [adjusting to changes in relationships and 
roles] (Cohen & Lazarus, 1979; Siegel & Krauss, 1991). Thus, behavioral 
responses to HIV, as with any chronic illness, may be influenced by complex 
interactions between disease-related demands, emotional distress, support resources, 
and patterns of coping.
The psychological and social sequelae of HIV and AIDS may have an 
important impact on behavioral responses to the disease. Adequate psychosocial 
functioning is likely to be associated with more active involvement in medical 
management (Siegel & Krauss, 1991; Namir et al., 1987). Consistent medical care
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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is crucial for prolonging life and improving qualiQf of life among people with HIV 
infection. Thus, psychosocial influences on patients' seeking treatment and adhering 
to prescribed medical regimens are arguably an issue of grave importance.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
NONADHERENCE 
Nonadherence among individuals with HIV and AIDS must be viewed within 
the context of chronic illness and nonadherence to medical regimens in general. 
Therefore, a brief overview of the field of medical noncompliance will first be 
presented.
Definition of Nonadherence
Broadly defined, the terms nonadherence and noncompliance denote the 
degree to which behavior fails to coincide with medical or health-related advice. 
Although "nonadherence" and the older label of "noncompliance" are synonyms 
describing this pervasive threat to health care, nonadherence is the term that is now 
advocated by some researchers (Dunbar-Jacob, Burke, & Puczynski, 1995) because it 
has more of a collaborative connotation for describing patient and physician 
interactions (Gerber, 1986). Nonadherence can be operationally defined in a variety 
of ways. For example, nonadherence classifications may refer to any minute 
deviation from a treatment regimen, or to adherence percentages below 80% of 
prescribed treatment demands (Carr and Maxim, 1983). Definitions of nonadherence 
which express the concept as the percentage of total regimen followed are widely 
regarded as the most valid and sensitive measure, and may allow adherence 
assessment to lead most easily to measurable interventions (Dunbar, 1979). 
Nonadherence and Chronic Illness
Nonadherence is a major health care problem among chronically and 
terminally ill patients (Gerber, 1986, German, 1988). The therapeutic benefits of
16
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health care are commonly jeopardized by chronically ill individuals because they do 
not consistently adhere to prescribed medical regimens (German, 1988; Dunbar- 
Jacob, Burke, &  Puczynski, 1995). The prevalence of medical nonadherence has 
been widely documented and has remained at a 6 irly stable rate for more than two 
decades (Dunbar-Jacob, Dwyer, &  Dunning, 1991). Estimates indicate that half of 
medical patients do not take prescribed medications, that 20-80% drop out of long 
term treatments, and that as many as 20-50% of medical t̂ pointments are missed 
(Becker, 1985; Sackett, 1976; Sackett & Snow, 1979; Turk, Meichenbaum, & 
Genest, 1983). Every patient is at risk for nonadherence. At some time in the 
course of treatment, as many as 80% of medical patients may be at least partially 
nonadherent (Dunbar-Jacob, Burke, &  Puczynski, 1995). Nonadherence has a 
significant impact on medical care among individuals of all ages and sociocultural 
groups. Although socio-economic status has been shown to influence rates of 
nonadherence in some studies, the findings are equivocal and appear to vary across 
diseases (Tagliacozzo & Ima, 1970; Gravely & Oseasohn, 1991; Roberson, 1992). 
Overall, the literature suggests that: (a) patients' demographic characteristics are the 
least relevant to nonadherence, (b) psychosocial factors are understudied and 
inconsistently associated with nonadherence, and (c) specific characteristics of 
medical regimens are the most clear predictors of low adherence (Dunbar-Jacob et 
al., 1995).
Determinants of nonadherence may depend to some extent on the medical 
population being studied, the definition of adherence employed, and the type of
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medical regimen prescribed (Carr and Maxim, 1983; Dunbar-Jacob, Burke, &  
Puczynski, 1995; Sherbourne, Hays, Ordway, Dimatteo, & Kravitz, 1992). 
Characteristics of medical regimens that have most consistently been found related to 
nonadherence include greater complexity of interventions (Agras, 1989; Goodall &  
Halford, 1991; Blackwell, 1992) and greater duration of interventions (Agras, 1989; 
Richardson, 1986; Goodall &  Halford, 1991). Complex interventions may require 
too much behavior change for patients to adhere to the regimen (Anderson, 1990). 
Likewise, the demands of long term maintenance of treatment regimens exceed many 
patients' tolerance for health-related behavior change. Nonadherence tends to 
increase over time and it is also likely to increase if a treatment regimen entails 
unpleasant side-effects (Agras, 1989; Blackwell, 1992). Characteristics of certain 
diseases have also been hypothesized to be linked to adherence problems. For 
example, if patients are asymptomatic or have difficulty identifying signs of 
improved health, adherence to prophylactic regimens may be less likely to be 
maintained. The relevance to nonadherence of psychosocial factors such as social 
support, avoidant coping strategies, and depressive and anxiety symptoms also appear 
to vary across different chronic diseases (Blumenthal et al., 1982; Boyer et al., 1990; 
Kulik & Mahler, 1993; Dunbar-Jacob et al., 1995; German, 1988; Kiecolt-Glaser & 
Williams, 1987; Sherbourne et al., 1991). Thus, individuals with chronic illnesses 
which are likely to threaten psychosocial functioning or to require complex, long 
term, or prophylactic medical care may potentially be at high risk for medical 
nonadherence.
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Nonadherence and HIV
Unfortunately, both the recommended regimens for medical management of 
HIV/AIDS and the disease process itself possess many characteristics which have 
been suggested as predictors of nonadherence (Chesney &  Folkman, 1994; Dunbar- 
Jacob et al., 1995). HIV is a highly stigmatized virus that affects socially 
disenfranchised individuals in high proportions. The disease course begins with a 
lengthy asymptomatic phase and is often perceived as uncertain or uncontrollable. 
Treatment regimens offer no hope for a cure and frequently require adherence to 
lengthy, complex treatments which may be prophylactic or entail negative side 
effects. Particularly high rates of medical nonadherence have been documented 
among patients both early and late in the disease course. For example, rates of 
treatment refusal among hospitalized AIDS patients have been reported to reach 90% 
(Blumenfield, Milazzo, & Wormser, 1990), asymptomatic research participants have 
been found to drop out of AZT trials at a rate of nearly 30% (Fischl et al., 1990), 
and among HIV outpatients rates of 23% nonadherence to AZT regimens have been 
described (Samet et al., 1992). To put these nonadherence rates into perspective, 
70% of leukemia inpatient controls refused some treatment in Blumenfîeld's (1990) 
study, and attrition rates for clinical trials treating other chronic diseases (e.g., beta 
blockers for cardiovascular disease) are generally less than 10% (Bell et al., 1985; as 
cited in Chesney & Folkman, 1994).
Only a very small number of studies have directly explored adherence to HIV 
medical interventions. This is surprising given the weight medical care providers
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working with HIV-infected patients appear to place on this issue, and given the 
potential impact of treatment adherence on both the quality and quantity of life 
throughout the HIV/AIDS disease spectrum. Some research has explored adherence 
to specific HIV-related pharmacologic regimens. Opravil, Weber, Ledergerber, 
Speich, Siegenthaler, and Luthy (1990) found a relationship between PCP relapse 
and nonadherence to pentamidine prophylaxis among AIDS patients. Those who 
failed to adhere to their prophylactic treatment regimen displayed higher pneumonia 
relapse rates than did adherent patients. Other studies have documented that 
nonadherence and drop-out rates among AZT drug trial participants are highly 
problematic (e.g., Fischl et al., 1990; Morse, Simon, Cobum, Hyslop, Greenspan,
& Balson, 1991). Several recent and preliminary studies have examined 
nonadherence to HIV outpatient appointments. Using archival data collected from 
two public HIV clinics, Kissinger and colleagues (1995) found that 15 % of clients 
failed to attend the ideal number of visits suggested by treatment guidelines (i.e., 1 - 6  
appointments during a 6 -month period depending on disease status). In this study, 
patients who missed appointments were more likely to be immunocompromised, to 
be African-American, and to have a history of IV  drug use (Kissinger, Cohen, 
Brandon, Rice, Morse, & Clark, 1995). Similarly, a pilot study conducted at a 
public hospital in Baton Rouge, in which nonadherence was measured in terms of the 
percentage of actual appointments scheduled, found that 36% of appointments were 
failed (Catz et al., 1995). The same rate of appointment fitilure was documented
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during a randomly sampled one-week period by Shelton and colleagues (1993) among 
women scheduled to attend an H IV clinic at a large Miami hospital.
Even fewer studies have examined the role of psychosocial factors in the 
prediction of HIV-related nonadherence. O f the limited studies identified in a 
comprehensive review of the literature, none empirically investigated this research 
question with methodological rigor. For example, although hopelessness was 
proposed as a causal factor for medical nonadherence in a study in which AIDS 
patients' treatment refusal rates were found to be four times higher than leukemia 
patients, this hypothesis was not empirically tested by the researchers (Blumenfield, 
Milazzo, & Wormser, 1990). Morse and colleagues (1991) used a vaguely defined 
methodology of questionable validity to evaluate asymptomatic HIV-positive subjects' 
adherence within an experimental drug protocol. Research participants were 
identified as compliant or noncompliant to the protocol on the basis of nurses' rank 
ordering of subjects in terms of an undefined level of perceived "compliance." The 
authors interpreted their results as suggesting that research subjects perceived as most 
compliant lived further from the treatment site, didn't live alone, viewed nursing 
staff as supportive, and were more likely to depend on a specific person for social, 
economic, and emotional support (Morse et al., 1991). In another exploratory study, 
Shelton and colleagues (1993) interviewed four pregnant, seropositive, African- 
American women and their families for the purpose of identifying factors 
contributing to their medical nonadherence. They concluded that transportation, 
child care, concern for the health of the fetus, the presence of concerned family
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members, and substance abuse were most relevant to health care behaviors among 
these women (Shelton, Marconi, Pounds, Scopetta, O'Sullivan, & Szapocznik,
1993). In sum, several psychosocial Actors (e.g., hopelessness and social support) 
have been proposed to contribute m medical nonadherence among HIV-positive and 
AIDS patients (Blumenfield, Milazzo, & Wormser, 1990 ; Morse et al., 1991; 
Shelton et al., 1993). Unfortunately, the studies investigating these Actors have thus 
far been limited in both scope and methodology.
Given the paucî  of investigations integrating the adherence and HIV  
literatures, the most pertinent information from each area will be presented below in 
an attempt to elucidate relevant factors likely to impact nonadherence to HIV-related 
medical care. A discussion of six psychosocial and medical care factors thought to 
be most pertinent will be followed by a brief discussion of how adherence should be 
measured in HIV outpatient populations.
Social support.
Social support has been described as one of the few psychosocial variables 
clearly implicated in medical nonadherence (Gravely & Oseasohn, 1991). Generally 
speaking, individuals with poor social support are less likely to be adherent than 
individuals with good social support systems (Agras, 1989). For example, in a 
longitudinal study of patients with three different chronic medical conditions 
(hypertension, diabetes, and heart disease), Sherbourne, Hays, Ordway, Dimatteo, & 
Kravitz (1992) found a strong link between improved diabetic adherence and 
increased quality (but not quantity) of social support. Likewise, greater emotional
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support from spouses was a signifîcant predictor of lower emotional distress, better 
quality of life perceptions, and adherence to lifestyle changes among cardiac surgery 
patients (Kulik &  Mahler, 1993). Similarly, social support was demonstrated to be 
a good predictor of medical adherence, operationalized in terms of both pill-count 
ratios and percentage of kept appointments, among patients with hypertension 
(Stanton, 1987). Thus, a positive relationship between social support and adherence 
has been a fairly consistent finding across a variety of chronic illness samples.
Kalichman (1995) suggests that social support leads to treatment seeking 
behavior and to enhanced treatment adherence among HIV populations, just as it has 
been demonstrated to promote these health-related behaviors in general (House, 
Landis, &  Umberson, 1988). Patients who have any chronic disease may require 
extra support or have a higher likelihood of straining their social support networks 
(Schulz &  Williamson, 1991). This is potentially even more true of HIV-infected 
individuals due to the social stigma, loss of employment networks, and social 
isolation from family and peers often associated with the disease (Hays, Chauncy, & 
Tobey, 1990). Thus, one might expect the magnitude of the relation between poorer 
social support and increased medical nonadherence to be even greater for HIV- 
positive patients than for those with other, less stigmatized or disabling chronic 
illnesses. Cohen's (1988; Cohen & Wills, 1985) three dimensions of social support, 
which include emotional support [affection or compassion], informational support 
[advice or new knowledge], and instrumental/tangible support [practical assistance in 
the form of services or materials], have all been demonstrated to promote
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psychosocial adjustment among HIV-infected individuals (Hays, Turner,& Coates, 
1992; Rabkin et al., 1990). Instrumental support, in the form of assistance with 
tangible everyday needs (e.g., transportation to medical appointments, medication 
reminders) may be especially relevant to HIV-related treatment adherence due to the 
impairments in daily functioning experienced by many patients. Also, emotional 
support increases hope among HIV-positive individuals (Rabkin et al., 1990; Zich & 
Temoshok, 1987), which may in turn promote treatment adherence.
Hopelessness.
The general adherence literature lacks investigations speciOcally examining 
the role of hopelessness as a predictor of nonadherence among the chronically ill. 
However, affective distress in general has been proposed to increase physical illness 
by increasing the probability of poor health behaviors, including medical 
nonadherence (Cohen & Rodriguez, 1995). For example, studies with hemodialysis 
patients (Tracy, Green, & McCleary, 1987) and with cancer patients (Ayeres, Hoon, 
Franzoni, Matheny, Cotanch, & Takayanagi, 1994) yield mixed results regarding the 
hypothesized relationship between emotional distress and nonadherence. Increased 
depression among hemodialysis patients has been related to increased dietary, fluid, 
and medication nonadherence; whereas in an oncology setting, increased depression 
and anxiety were associated with increased adherence to chemotherapy appointments 
(Ayeres et al., 1994; Tracy et al., 1987). In sum, no clear relation between 
depression and nonadherence has emerged from the chronic adherence literature and 
the role of hopelessness within this context has not been specifically examined.
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In one of the few studies bridging the fields of HIV and medical adherence, 
however, Blumenfield and colleagues (1990) suggested (but did not test) the 
hypothesis that depression among AIDS patients results in hopelessness, which in 
turn results in nonadherence in the form of giving up and refusing treatment 
procedures. Conceptually, the role of hopelessness in predicting nonadherence can 
be viewed within the context of the Health Beliefs Model (Becker et al., 1979). A 
belief that the disease will improve with treatment is a central tenant of this medical 
adherence model (Nagy & Wolf, 1984). Thus, loss of hope for the future is very 
likely to be related to HTV-infected individuals' motivation to seek out and adhere to 
medical treatment. In light of the earlier discussion of measurement issues 
regarding an overlap of depressive and HIV symptoms, and the relative conceptual 
and methodological importance of hopelessness as an index of distress among HIV- 
infected individuals (Kalichman, 1995; Rabkin et al., 1990), a direct empirical test of 
the hopelessness-nonadherence relation appears warranted.
RçligiptM Coping,
A review of the adherence literature suggests that, with the possible exception 
of avoidance coping or denial, general coping strategies have not been consistently 
linked to adherence among chronically ill patients (Dunbar-Jacob et al, 1995; 
Sherbourne et al., 1992). Strategies more specific to terminal illness, such as 
religious coping, have not been adequately developed within the current body of 
adherence knowledge. Likewise, although a number of studies have examined the 
relations between religiosiQr and both psychological and physical health, none which
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included adherence were identifîed in a systematic review of this literature (Larson,
1993). Relevant research has documented the importance of religious coping in 
ads t̂ation to life-threatening disease, however. Religiosî  has been associated with 
reduced distress, increased social support, and improved health outcomes among a 
wide range of medical populations (Larson &  Larson, 1994), For example, some 
pertinent findings among outpatient, hospitalized or advanced stage oncology patients 
include: (a) religious values are related to decreased anger, distress, and social 
isolation and to increased life meaning (Acklin, Brown, & Mauger, 1983); (b) 
religiosity is linked to decreased anxiety (Kaczorowski, 1989); (c) perceptions of God 
as a source of external control are positively correlated with adjustment to cancer 
(Jenkins & Pargament, 1988); and (d) increased religious activities may enhance 
emotional well-being (Yates, Chalmer, St. James, Follansee, & McKegney, 1981).
For many medical patients, the difficulties of facing a life-threatening illness 
are often met with an increased reliance on religious belief. A recent finding that 
prayer is the single most frequently endorsed coping strategy used to deal with HIV 
status among a heterogenous, low SES sample of infected outpatients supports this 
contention (Jones et al., 1996). Similarly, Kalichman (199S) found that as many as 
40% of HTV-infected individuals report finding new Aith, while more than 60% 
frequently hope that a miracle will happen. Religious practices and beliefs may 
serve several important purposes for people with HIV infection. Beliefs in a higher 
power and social support from a religious community may both be sources of 
emotional support (Kalichman, 1995). Spiritual coping may also serve to guide
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problem-solving (Folkman et al., 1992). Many anecdotal and case study 
investigations have implied that increased importance of religious beliefs and 
behaviors in response to HIV may stem from a search for meaning (Carson, Soeken, 
Shanty, &  Terry, 1990; Kendall, Gloerson, Gray, McConnell, Turner, & West,
1989; Moynihan, Christ, & Silver, 1988). All terminal illnesses, but particularly a 
stigmatized and unpredictable syndrome like HIV/AIDS, may raise spiritual questions 
regarding the meanings of life and suffering, the nature of death, and how to come to 
terms with feelings of punishment or lost control. Carson and colleagues (1990) 
have also suggested that spiritual well-being is strongly linked to hope among 
individuals living with AIDS.
The importance of religious coping among HIV populations is just beginning 
to be researched. Thus far, the use of religious/spiritual behaviors and coping 
strategies among HIV-infected individuals has been suggested by empirical studies to 
have a role in immune functioning, psychological distress, and high risk sexual 
behaviors (Folkman, Chesney, Pollack, &  Phillips, 1992; Franks, Templer, 
Cappelletty, &  Kauffman, 1990; Somlai, Kelly, Kalichman, Mulry, Sikkema, 
McAuliffe, Multhauf, &  Davantes, 1996; Woods, Antoni, Ironson, & Kling, 1996).
A ground-breaking study by Woods and colleagues (1996) found that endorsement of 
religious behaviors was associated with higher T-cell counts, whereas endorsement of 
religious coping was significantly associated with less depressive and anxiety 
symptomatology among 106 HIV-infected gay men. In a particularly strong 
conceptual investigation of spirituality, coping and emotional distress among a
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heterogenous sample of 65 individuals with HIV or AIDS, religious beliefs and 
practices were strongly associated with lower levels of depression, anxiety, 
suicidality, and loneliness (Somlai et al., 1996). In an investigation conducted by 
Folkman and colleagues (1992) in San Francisco, spiritual activities (i.e., religious 
service attendance, personal meditation, reading spiritual literature, consulting a 
religious leader, and talking to others about spiritual concerns) were inversely related 
to high-risk sexual behaviors among 398 gay and bisexual men. This is important 
because the study demonstrated a link between religious behavior and health behavior 
(Folkman et al., 1992). In sum, newly emerging research indicates that religious 
coping is an important construct to address in future investigations of psychosocial 
functioning and health-related behaviors among HIV-infected individuals.
Stage of illness.
As discussed earlier, high rates of medical nonadherence have been 
documented among patients both early and late in the course of HIV infection 
(Blumenfield et al., 1990; Fischl et al., 1990). The limited number of studies 
examining adherence rates among H IV and AIDS patients have primarily looked at 
adherence during one point along the disease continuum. To date, no known studies 
have directly compared nonadherence rates across different phases of the HIV 
disease spectrum.
Given that adherence is hypothesized to be related to social support, coping, 
and distress among HIV-infected individuals, it should be noted that several studies 
have explored variations in these psychosocial variables across disease status groups.
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One relevant study conducted by Pakenham, Dadds, and Terry (1994), yielded 
ambiguous results regarding the relation of social support and coping across 
symptomatic and asymptomatic HIV-positive individuals. The study did not include 
AIDS patients in the comparison. The authors' interpretation was that relations 
between coping strategies and psychosocial adjustment didn't vary across disease 
stages, but that some components of social support (level of emotional support and 
frequency of social contact) did vary across HIV phases. Also of interest, several 
studies have yielded equivocal results regarding the relationship between distress 
symptoms and immune markers for disease progression (Chuang et al., 1989; Kelly 
et al, 1993; Perry et al., 1992). The majority of research in this area has examined 
emotional distress during only a single point along the HIV/AIDS continuum, or has 
not directly compared psychosocial functioning across the three major phases of 
Illness.
Chronicitv of treatment.
One very consistent determinant of medical nonadherence is the length of 
treatment (Dunbar-Jacob et ai., 1995). Nonadherence usually increases over time.
In general, the longer a treatment regimen must be adhered to, the less likely 
adherence will be maintained (Agras, 1989; Richardson, 1986; Goodall & Halford, 
1991). During the course of disease progression from HIV infection to AIDS, 
patients must repeatedly return for medical care over time. Medical management of 
the disease may entail a long series of treatment demands. Patients are expected to 
have blood drawn regularly for the purpose of monitoring immune status. A number
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of medical contacts may be required to screen for or provide prophylaxis for various 
opportunistic diseases (U.S. Department of Health and Human Services, 1994).
Many common HIV/AIDS-related pharmacological interventions (i.e ., antiretroviral 
medications, PCP preventive agents) involve adherence to long term drug regimens. 
Thus, it is highly likely that 6 ctors such as the length of medical care may predict 
treatment adherence among HIV-infected outpatients.
Consistencv of Care.
The importance of provider/patient relationships has been another long 
established research finding. The quality of provider/patient interactions can affect 
patients adherence to appointments as well as to other medical instructions (Sharbaro, 
1990). Patient satisfaction with medical care and consequently, adherence, may be 
influenced by 6 u:tors identified in the early adherence literature such as physician 
communication skills, warm interactional style, and willingness to address patient 
concerns (Davis, 1978; Korsch & Negrete, 1972). Besch (1995), in a later review of 
literature relevant to adherence in AIDS clinical drug trials, concluded that continuity 
of care may be an important factor in increasing adherence. Consistent medical care 
by a provider over time may be important because it provides opportunities for 
patients to build trust in physicians and to ask questions.
Assessment of adherence to HIV/AIDS regimens.
Medical nonadherence may be measured in numerous ways (e.g., missed 
medical appointments, procedures refused, pill counts, medication blood levels, 
medical staff ratings, patient self-reports) (Dunbar-Jacob et al., 1995). Adherence
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measures that rely on self-report or indirectly monitored behaviors are problematic. 
For example, the most nonadherent patients are least accurate in their self­
descriptions of adherence (Mazur, 1981). In the context of an outpatient HIV clinic, 
missed medical appointment are therefore likely to be a relatively more reliable 
nonadherence measure. More importantly, a meaningful measure of nonadherence 
across the HIV/AIDS disease spectrum must take into account the extensive 
variabili^ in treatment regimens necessitated by the widely varying natural course of 
infection. Attendance at medical t̂ pointments serves, in a sense, as a "common 
denominator” of adherence to diverse HIV-related treatment regimens (e.g., 
prophylactic, symptom alleviating, pharmacological, or lifestyle change 
interventions). In other words, every patient infected by HIV or diagnosed with 
AIDS must first show up for appropriate medical care in order to receive or benefit 
from it.
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PURPOSE OF THE STUDY
Given the importance of medical interventions in slowing disease progression 
and improving quality of life among HIV-infected individuals, the present study 
attempted to identify psychosocial and medical care factors predictive of 
nonadherence to outpatient HIV treatment services. Based on pilot data indicating 
36% of medical appointments in this population are not attended, nonadherence was 
measured in terms of outpatient HIV clinic attendance. Percentage of medical 
appointment attendance appeared to be the measure of choice for comparisons across 
the HTV/AIDS disease spectrum, since all patients must consistently seek medical 
care in order to benefit from it. The primary purpose of the study was to identify 
factors associated with patients not returning reliably for medical services.
Therefore, the constructs of social support, religious coping, and hopelessness were 
explored among HIV-positive outpatients varying in length of treatment and disease 
status in terms of their subsequent medical nonadherence (as monitored over an 
approximately 6 -month period of time). Specifically, the present study sought to 
address three research questions.
First, do psychosocial Actors (hopelessness, religious coping behaviors, 
perceived social support) and medical care factors (length of treatment, disease 
status, physician consistency) predict percentage of medical appointment 
nonadherence? It was hypothesized that psychosocial factors would add signiOcantly 
to the variability in nonadherence accounted for by medical care Actors. Although 
precise predictive tests of HIV-related nonadherence had not yet been conducted, a
32
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synthesis of nonadherence research with other chronic medical conditions (e.g., 
Agras, 1989) and the psychosocial H IV  literature (e.g., Rabkin et al., 1990; Siegel 
& Krauss, 1991; Somlai et al, in press) suggested these variables would be predictive 
of nonadherence in HIV and AIDS patients. Specifically, it was hypothesized that 
longer duration of medical care, less consistent care, and less adequate psychosocial 
functioning (i.e., high levels of hopelessness and low levels of social support and 
religious coping) would be associated with greater nonadherence. Given the lack of 
empirical investigation of nonadherence to HIV-related treatment, the relative 
predictive strength of these variables was unknown. Therefore, while the study 
explored the unique contribution of each psychosocial and medical care variable in 
the prediction of nonadherence, no hypothesis was advanced regarding which 
variables would be the most powerful predictors.
Second, would outpatients vary in terms of psychosocial adjustment and 
coping resources (hopelessness, religious coping, social support) across disease status 
groups (HTV-infected, immunocompromised, AIDS)? Just as the medical demands 
may be different across the diagnostic spectrum, emotional responses may also be 
difierent for patients who are confronting the fact that the virus is taking its toll or 
those who are hopeful it will be many years before they contract an AIDS-related 
disease. Much of the existing literature has examined general coping, support, or 
distress during a single point along the HIV/AIDS continuum or has not directly 
compared the psychosocial functioning indices of primary interest in the present 
study across the three major phases of illness (Chuang et al., 1989; Kelly et al.
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1993; Pakenham et al., 1994; Perry et al., 1992). Thus, although prior research 
suggested that psychosocial functioning changes across the H IV disease spectrum, 
there was not a firm basis for specific directional hypotheses regarding differences in 
hopelessness, religious coping, and social support at different stages of illness.
Third, would outpatients vary in medical nonadherence across disease status 
groups (HIV-infected, immunocompromised, AIDS)? Subjects were categorized into 
discrete groups to address this question because of the psychosocial and medical 
implications associated with diagnostic status. The medical demands may be very 
different for a patient who is asymptomatic, one who has already received an AIDS 
diagnosis, or one who has just been prescribed AZT for the first time after their T- 
cell count drops below 500. Although no research to date had explored this question 
directly, the hypothesis was based on the well-documented premise that patients at 
different phases along the HIV-AIDS disease spectrum are asked to adhere to very 
different treatment regimens (U.S. Department of Health and Human Services,
1994).
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Subjççt$
Volunteers were recruited during their medical appointments at an ambulatory 
care HIV clinic located at Earl K. Long Medical Center, a public hospital in Baton 
Rouge. H IV seropositive outpatients were eligible to participate in the study if they 
could read and were at least 18 years old. One-hundred-seventy-three (173) patients 
agreed to participate. Of these participants 13 were ineligible (i.e., 1 was later 
determined to be HIV seronegative and 12 were excluded due to incomplete or 
invalid responses), resulting in an initial 160 participants whose outpatient 
appointments were followed over time. One multivariate statistical outlier was later 
excluded from the initial sample of 160, yielding an N of 159 participants who were 
included in at least one of the study's main analyses. Demographics of all 159 
participants are presented in Tables 1 and 2 below, whereas descriptive information 
about subsets of the sample used in specific analyses are presented in the results 
section.
Eight participants who expired within the 7-month study period were excluded 
a priori from follow-up appointment attendance analyses. One additional participant 
was excluded, as he primarily used a private physician rather than the public hospital 
clinic, yielding a final follow-up H  of 150 for whom valid attendance and disease 
status data were obtained. Only 144 participants both completed all study measures 
and survived the study period. Thus, the total number of participants included in 
the analysis of primary interest was 144.
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The total sample was comprised of 57 African-American females (35.8%), 48 
African-American males (30.2%), 39 Caucasian males (24.5%), 12 Caucasian 
females (7.5%), 2 Hispanic males (1.3%), and 1 Hispanic female (0.6%). Fifty-two 
(32.7%) reported a history of injection drug use (IVDU) and 63 (39.4%) reported 
sexual contact with injection-drug users as an infection risk factor. Fifty of the 
participants had AIDS, 72 were in the immunocompromised range (CD4  200-500), 
and 36 of the participants were HIV-infected (CD4  > 500) [See Table 2]. Of the 8  
subjects who expired prior to completing the study, 4 were African-American and 4 
were Caucasian. Five of the deceased participants were male, 3 were female, 3 were 
homosexual/bisexual, and 1  was a drug-injector.
Two-hundred-fifty outpatients were contacted for recruitment (i.e., an 
additional 77 patients were contacted who did not or could not participate in the 
study). Thirty-nine of those contacted were ineligible; 37 had reading, visual,or 
comprehension problems which prevented them from completing questionnaires, 1  
did not speak English, and 1 was intoxicated. Of the patients who refused to 
participate, 17 gave no reason, 16 declined due to time constraints, 2 declined due to 
physical symptoms, 2  indicated they were concerned about confidentially, and 1  
refused due to childcare responsibilities. Overall, 159 (63.6%) of the 250 patients 
contacted were eligible volunteers, with 144 (90.5%) of them completing all aspects 
of the study.
A consecutive patient sampling procedure was employed to maximize the 
number of patients contacted for research participation. The HIV clinic from which
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participants were recruited provides medical services, health education, and social 
services for HIV-infected outpatients. Letters confirming clinic appointment times 
were routinely sent to patients, and transportation to the clinic was available through 
an AIDS community service organization. The clinic is located at a public teaching 
hospital serving a primarily low SES, medically uninsured population.
Materials
Nonadherence Measure.
Nonadherence was defined as the percentage of total medical appointments 
no-showed during a 7-month period at the outpatient HIV clinic. Specifically, 
nonadherence was measured by tallying the total frequency of appointments 
scheduled (excluding those conflicting with hospital inpatient stays), tallying the 
frequencies of appointments attended and missed, and then calculating the percentage 
of total clinic visits recorded as missed due to no-shows. The data collection period 
was 7 months to ensure that "6 -month” follow-up appointments were included in the 
measure during times when clinic holiday closures caused scheduling conflicts. In a 
pilot study conducted by Catz, McClure, Jones, and Brantley (1995), two indices of 
appointment nonadherence were calculated: (a) percentage of "no shows" for total 
nurse and physician appointments scheduled, and (b) percentage of total appointments 
missed (including both cancellations and no shows). Although missed appointments 
were operationalized in two ways to investigate whether including cancelled/ 
rescheduled appointments would improve the predictive ability of the "no show" 
measure, the results of the pilot study indicated that it did not do so (Catz et al..
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Heterosexual 1 1 1 69.8








Female 1 0 . 6
IVDU 52 32.7
Caucasian 13 8 . 2
Minority 39 24.5
Male 32 2 0 . 1
Female 2 0 1 2 . 6
IVDU Partner 63 39.4





< $ 1 0 , 0 0 0 130 81.8
$ 1 0 -2 0 , 0 0 0 24 15.1
$20-30,000 5 3.1
Deceased 8 5.0
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Table 2. DEMOGRAPHIC COMPOSITION BY DISEASE STATUS GROUPS
CD4 < 2 0 0 CD4  200-500 CD4  >500
N % N % N %
Gender
Male 33 20.9 39 24.7 16 1 0 . 1
Female 17 1 0 . 8 33 20.9 2 0 12.7
Race
Caucasian 2 2 13.9 2 2 13.9 7 4.4
Minority 28 17.7 50 31.7 29 18.3
IVDU
Drug injector 16 1 0 . 1 24 15.2 1 2 7.6
Non-drug injector 34 21.5 48 30.4 24 15.2
Total Sample 50 31.6 72 45.6 36 2 2 . 8
M SD M SD M s a
Age 33.3 7.51 34.18 7.99 34.13 9.56
Education 12.37 2.65 12.40 2.16 11.75 2.23
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1995). Therefore, the present study utilized only "no show" rates as the index of 
medical appointment nonadherence. Percentage of appointments was used rather 
than frequency to reduce the confounds inherent in variable numbers of appointments 
being scheduled (e.g., due to patient health status, physician availability, and clinic 
space limitations).
Psvchosocial Measures.
The Beck Hopelessness Scale (BHS) is a 20-item true-üüse scale for 
measuring negative expectations about the immediate and long-range future (Beck, 
Weisman, Lester, & Trexler, 1974; Beck & Steer, 1988). It has been used to assess 
hopelessness and suicide risk in a variety of populations, including HIV samples 
(Rabkin et al., 1990; Steer, Iguchi, &  Platt, 1994). The scale has demonstrated high 
internal consistency across clinical samples (KR-20 range =  .82-.93) and adequate 
test-retest reliability (.69). Concurrent validity of the BHS has been established with 
comparisons to clinical ratings of hopelessness (.74) and the Beck Depression 
Inventory pessimism item (.63). BHS scores range from 0 to 20, with higher scores 
reflecting greater hopelessness. Scores indicative of mild hopelessness range from 4 
to 8. Cut-off scores of 9 indicate moderate hopelessness and scores of 14 or greater 
represent severe hopelessness.
The Interpersonal Siq>port Evaluation List (ISEL) is a 40-item questionnaire 
designed to measure perceptions of social support availability (Cohen, Mermelstein, 
Kamarck, & Hoberman, 1985). Respondents rate each statement on a 4-point, true- 
false scale indicating how accurately it describes their social support. Four domains
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of social support are tapped by the ISEL. Aggregate perceived social support scores 
are generated by combining scores of four subscales (Appraisal, Belonging, Self­
esteem, and Tangible). Higher ISEL scores are indicative of greater perceived social 
support. The ISEL has demonstrated adequate construct validity as a predictor of 
distress among HTV-infected outpatients (McClure, Catz, Prejean, Brantley, & Jones,
1996), as well as acceptable test-retest reliabili^ for aggregate scores in general (.87) 
(Cohen, Mermelstein, Kamarck, & Hoberman, 1985).
The Ways c f Religious Coping Scale (WORCS) is a 40-item self-report 
measure assessing the degree to which subjects engage in religious behaviors to cope 
with stressful situations (Boudreaux, Catz, Ryan, Melendez, & Brantley, 1995). 
WORCS items are rated on a 5-point Likert scale from not used at all' to used 
always'. The behaviors included in the scale range from internally focused processes 
such as prayer to externally focused processes such as participating in a church 
support group. The WORCS yields a total score and two factor-analytically derived 
subscale scores (Internal/Private and External/Social). The measure has been found 
to be internally consistent (.95) and to have adequate concurrent and discriminant 
validity as compared to measures of religious service attendance, ratings of the life- 
importance of religion, social desirability, and other religious coping questionnaires 
(Boudreaux et al., 1995). The validity of the WORCS for use with general medical 
patients and those with chronic illnesses including HIV has also recently been 
demonstrated (Catz, Davis, Boudreaux, Brantley, & Howe, 1996; Davis, Catz, 
Boudreaux, & Brantley, in press).
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Disease Status Measure.
HIV has the highest binding affini^ for T-helper lymphocytes with CD4  
surûice molecules (Fauci, 1988). Thus, HIV selectively destroys CD* cells. The 
most conunon index of disease status among HIV-infected patients during the course 
of the present study was therefore absolute CD* T cell counts (Kelly & St.
Lawrence, 1988). Current Center for Disease Control guidelines base 
immunosuppression status (CD* <  500) and AIDS diagnosis (CD* <  200) on counts 
of CD* cells per cubic milliliter of blood (CDC, 1992). Baseline CD* counts were 
therefore monitored in the present study through medical chart review of routine 
laboratory reports. Analyses of blood drawn at Earl K. Long Medical Center are 
routinely conducted at the Medical Center of Louisiana, East Campus in New 
Orleans. The procedures employed by this laboratory for obtaining CD* counts are 
as follows. Absolute CD* counts are determined by mixing blood samples with 
fluorescence tagged monoclonal antibodies, which are incubated with a dual-color 
mixed cocktail of CD3  and CD* cells. Then, Coulter Q-Prep lysis is performed and 
flow cytometry analysis is conducted. To measure CD*%, FS V Log SS signals are 
then plotted and the lymphocyte region is gated for fluorescence analysis. Finally, 
absolute CD* counts (CD*/mm^) are calculated as the CD*% multiplied by the 
absolute number of lymphocytes.
Procedure
Consecutive H IV seropositive outpatients were recruited during intake clinic 
visits or physician visits. After giving informed consent [see Appendix], volunteers
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who met inclusion criteria were interviewed for demographic information (e.g., age, 
race, gender, education, income, H IV notification date, transmission risk group) and 
asked to complete a battery of psychosocial questionnaires. Baseline measures of 
coping, hopelessness, and social support were collected in conjunction with an 
ongoing research protocol. Patients were paid $5.00 for their research participation.
Following baseline data collection, nonadherence to medical appointments 
was collected through review of clinic appointment records. All scheduled physician 
and nurse visits at the HIV clinic were included. Frequencies of medical 
appointments scheduled at the HIV clinic, cancellations, and "no shows” at 
appointments were collected by the investigator. Prospective record review for the 
7-month period of the study began with subjects’ date of entry into the study.
Blood was drawn and CD4  results were recorded in medical charts according 
to routine outpatient clinic procedures. Disease status, length of treatment, changes 
in attending physicians, and other relevant medical data were obtained through 
review of patient medical records by the investigator.
Design
The study followed participants' medical nonadherence prospectively over 
time. The central focus of the study was a longitudinal analysis predicting future 
nonadherence from baseline demographic, medical care, and psychosocial factors. 
Subjects varied at baseline in terms of disease status and time lapsed since the onset 
of HIV clinic services, so that the full range of disease and treatment chronicity
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could be sampled. Cross-sectional analyses at baseline and at 7 months were also 
conducted. See Figure 1 for a schematic diagram of the research design.
{Regression Analysis}
Study Entry [---------------------------------------------------------------------------- ] 7 months
•  Psychosocial Indices • % Appointments No-showed
• niness Stage •  Physician Change Status
• Length of Treatment
(MANOVA: Psychosocial} (ANOVA: Nonadherence}
Figure I. SCHEMATIC LAYOUT OF STUDY DESIGN
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RESULTS
Descriptive statistics were computed for all demographic, psychosocial, and 
medical care variables to describe the characteristics of the sample and to screen for 
outliers. One outlier (>  3 SD) was excluded from the sample, as she appeared to be 
an unreliable respondent on several measures. The demographic composition for the 
portions of the sample who survived to complete the study and were included in the 
ANOVA and the regression analyses are presented in Tables 3 and 4. Of the 150 
subjects whose appointments attendance was tracked and compared cross-sectionally 
by disease status groups, 83 (55.3%) were males and 67 (44.7%) were females. One- 
hundred (66.7%) were African-American, 47 (31.3%) were Caucasian, and 3 (2.0%) 
were Hispanic. Approximately one third (34%) reported a history of injection drug 
use and 40.7% reported contact with an injection drug using sexual partner. Less 
than one third of the sample (30%) reported homosexual/bisexual orientation as a 
transmission risk. There was substantial overlap between transmission risk groups 
and gender/racial groups (see Table 3). A majority of subjects (83.3%) reported 
annual incomes below $10,000 with only 5 (3.3%) individuals earning more than 
$2 0 , 0 0 0  yearly.
Of the 144 subjects who were included in the longitudinal analysis predicting 
adherence from baseline information, 55 (38.2%) were African-American females,
40 (27.8%) were African-American males, 35 (24.3%) were Caucasian males, 11 
(7.6%) were Caucasian females, 2 (1.4%) were Hispanic males, and only 1 (0.7%) 
was a Hispanic female. As the number of Hispanic participants was too small for
45
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African-American 1 0 0 66.7
Caucasian 47 31.3




Minority 8 6 57.3
Male 39 26.0







Caucasian 1 2 8 . 0
Minority 39 26.0
Male 31 20.7
Female 2 0 13.3
IVDU Partner 61 40.7





< $ 1 0 , 0 0 0 125 83.3
$1 0 -2 0 , 0 0 0 2 0 13.3
$20-30,000 5 3.3
N = 150
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African-American 95 6 6 . 0
Caucasian 46 31.9
Hispanic 3 0 2 . 1
Orientation




Female 6 6 45.8
Homosexual/Bisexual 43 29.9
Caucasian 27 18.8




Caucasian 1 2 8.3
Minority 36 25.0
Male 27 18.8
Female 2 1 14.6
IVDU Partner 60 41.7
Caucasian 1 1 7.6
Minority 49 34.0
Male 2 2 15.3
Female 38 26.4
Income
< $ 1 0 , 0 0 0 1 2 0 83.3
$ 1 0 -2 0 , 0 0 0 2 0 13.9
$20-30,000 4 2 . 8
N = 144
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comparison purposes, they were included as part of a "minority” group in the 
regression analysis. As subjects were predominantly low income (83.3% <
$10,000; 13.9% =  $10-20,000; 2.8% > $20,000 annually), the meaningfulness of 
comparisons between economic groups in this sample was extremely limited. 
Transmission risk groups tended to vary in terms of their ethnic and gender makeup. 
For example, in this public hospital sample, those with a homosexual/bisexual risk 
factor were more likely to be Caucasian, while injection drug users were more likely 
to be minorities, and those reporting IV  drug using partners were more likely to be 
women or ethnic minorities (see Table 4).
Descriptive statistics for the factors investigated in the regression analysis are 
presented in Table 5. Education levels ranged from primary school (4th grade) to 
graduate school (19 years), with a mean 12th grade education. Mean subject age 
was 33.76, with the oldest subject aged 58. Immune status varied widely, with 
absolute CD4  counts ranging from 2 (i.e., end stage AIDS) to 1310 (i.e., normal 
immune functioning). The mean length of treatment at study entry for subjects 
completing the study was t̂ proximately one year, with treatment duration ranging 
from initial contact ( 0  months) to more than 4 years (51 months). Scale norms 
indicated that mean Beck Hopelessness Scale scores (M =  5.53) fell within the "mild 
hopelessness" range (Beck & Steer, 1988). Perceived social support as measured by 
the ISEL (M =  117.3) was higher in this sample with widely varying disease 
severity and treatment length, when compared to a mean of 81.5 found in an earlier 
study sampling only patients at their first appointments in the same clinic (McClure
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et al., 1996). Surprisingly, religious coping scores (M =91.6) were lower than in 
primary care and hemodialysis samples with which the WORCS has been employed 
(Davis et al., in press). Thus, participants surviving the study were characterized by 
mild hopelessness and relatively positive perceptions of social support, as well as 
relatively little use of religious coping strategies.
An exploratory correlation matrix was computed to examine continuous 
demographic variables (e.g., age, education, seropositive notifîcation time) and 
interrelations among all experimental variables (see Table 6 ). Age was positively 
correlated with education and length of diagnosis, and was negatively correlated with 
no-show percentage rates. Hopelessness was strongly and inversely related to social 
support and religious coping, and was weakly associated with percent appointments 
no-showed in the expected positive direction. Although social support was 
moderately related to no-show rates in the hypothesized negative direction, it should 
be noted that social support levels (but not no-shows) were also significantly 
correlated with greater education. The correlation ^  =  .42) between duration of 
treatment and months since HIV diagnosis suggests that the treatment length variable 
employed in this study somewhat reflects illness duration as well as treatment 
duration. Also of interest, percent appointments no-showed were weakly and 
positively related to CD* counts, but were not significantly associated with education, 
months since diagnosis, months of treatment, or coping.
For the categorical variables (e.g., gender, orientation, race, injection drug 
use, income), descriptive frequency and mean comparison analyses were also
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Table 5. DEMOGRAPHIC AND DESCRIPTIVE STATISTICS FOR STUDY 
COMPLETERS
Mean SD Range
Education 12.26 2.31 4-19
Age 33.76 8.14 18-58
Months of Treatment 12.33 14.31 0-51
CD4 350.7 269.09 2-1310
BHS 5.53 4.77 0 - 2 0
ISEL 117.31 23.18 59-159
WORCS 91.62 35.71 10-160
N =  144
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Table 6 . CORRELATION MATRIX OF DEMOGRAPHIC, INDEPENDENT AND 
DEPENDENT VARIABLES
1 . 2 . 3. 4. 5. 6 . 7. 8 . 9.
1. Age -  .23" .2 2 " -.2 1 " - . 0 1 .06 . 1 1 .06 . 0 2
2. Education — .16' -.15 - . 0 2 .2T* -.04 - . 0 0 - . 1 2
3. Months H IV + — . 0 2 .03 .09 .06 .42*" -.19*
4. % No Showed — .16' -.29*" .13 -.05 .18*
5. BHS — -.47"* -.36*** -.04 -.15
6 . ISEL .08 .09 . 1 0
7. WORCS — .05 . 1 0
8 . Months Treatment —— - . 1 0
9. CD4 —
*U <  .05 
<  .01 
* * * £  <  .001
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conducted for all experimental variables across demographic groups (see Tables 7- 
10). Substantial overlap was noted among demographic groups (e.g., Caucasians and 
men; %%e and education) and power limitations precluded examining more than two 
additional factors in the nonadherence model. Therefore, age and race were selected 
as relevant demographic variables to be controlled in the hierarchical regression 
model on the basis of their relatively strong relations to nonadherence in the 
descriptive analyses. Results indicated that minorities had significantly higher rates 
of nonadherence as compared to Caucasians ( i (148) =  4.14, g < .(X)l) and that 
younger age was significantly associated with greater nonadherence (r — -21, 
g <  .01). No significant associations or group dî erences in nonadherence were 
found for education, income, gender, sexual orientation, or injection drug use 
history.
DiAerences between participants who survived the study and those who died 
(n= 8 ) during the 7-month course of the study were examined. Deceased patients 
had more education (M =  14.6,1 (157) =  2.79, g <  .01) and they were more 
hopeless (M  = 1 0 .0 , t (157) =  2.42, g <  .05) than participants in general. 
However, the hopelessness of deceased patients was not signifîcantly different in 
comparison to other AIDS (CD*< 2CX)) patients who survived to be included in the 
adherence analyses. Deceased patients did not differ significantly from all survivors 
in terms of age, social support, coping, or treatment length.
It should be noted that of those who survived for 7 months after entry into 
the study, 5 patients had died by month 8 , 1 by month 9, and 3 were known to have
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died by month 12 after study entry. Thus, patients very near the end of their lives 
were included in the adherence analyses despite the necessary exclusion of patients 
who expired before the end of the appointment follow-up period. Additionally, the 3 
participants identified as receiving hospice care during a portion of the 7-month study 
period did not differ significantly in nonattendance rates from other participants, and 
so were retained in subsequent analyses.
Proportional data (i.e., percentage of appointments no-showed) by the nature 
of how it is derived, may not be normally distributed. Inspection of residual 
scatterplots suggested that the distribution of nonadherence data was negatively 
skewed, so an appropriate transformation (i.e ., arsine) of this percentage variable 
was performed to normalize the distribution prior to conducting further analyses 
(Cohen &  Cohen, 1983). For ease of interpretation, the raw appointment data are 
presented in tabular form (Table 11). Across all subjects surviving the study period, 
an average of 6 . 6  outpatient HIV clinic appointments were scheduled, with the 
frequency of scheduled ^pointments ranging from 2 to 23 during a 7-month period . 
Both the frequency of appointments missed due to no-shows alone and missed due to 
no-shows plus cancellations ranged from 0  to 8 , with means below 2  appointments. 
Approximately one fourth of scheduled appointments were no-showed (25.5%), with 
appointments missed due to cancellation/rescheduling about 4% higher (29.4%).
To test the primary research question, a multiple regression analysis was 
performed using a hierarchical regression of sets procedure (Cohen & Cohen, 1983) 
in which medical care variables were entered as a simultaneous block subsequent to
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Homosexual/ Bisexual 21 19
IVDU
Drug Injector 30 20





*p <  .05 
< .01 
<  .001
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Table 8. PSYCHOSOCIAL MEANS BY DEMOGRAPHIC GROUPS
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Table 9. MEDICAL GARE MEANS BY DEMOGRAPHIC GROUPS
CD4 Months Treatment
M m M SD
Gender
Male 298.39* 236.28 10.56 13.04
Female 392.41* 296.91 14.50 15.79
Race
Caucasian 257.82** 200.14 13.04 15.02
Minority 379.23** 287.68 11.96 14.17
Orientation
Heterosexual 349.76 272.05 13.23 14.95
Homosexual/ Bisexual 317.77 260.24 1 0 . 2 1 12.99
IVDU
Drug Injector 337.08 227.17 13.71 14.14
Non-Drug Injector 341.50 287.05 11.62 14.56
Income
< $ 1 0 , 0 0 0 353.62 275.35 12.50 14.30
$ 1 0 -2 0 , 0 0 0 284.42 233.15 10.63 15.86
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Table 10. PHYSICIAN CHANGE BY DEMOGRAPHIC GROUP FREQUENCIES
Physician Changed Physician Same
H N ChF
Gender
Male 1 2 71
Female 5 62 1 . 8
Race
Caucasian 8 39
Minority 9 94 2 . 2
Orientation
Heterosexual 1 0 95
Homosexual/ Bisexual 7 38 1 . 1
IVDU
Drug Injector 7 44
Non-Drug Injector 1 0 89 0.4
Partner
Drug Injector 4 57
Non-Drug Injector 13 76 2.3
Income
< $ 1 0 , 0 0 0 13 1 1 2
$ 1 0 -2 0 , 0 0 0 3 17
$20-30,000 1 4 0.7
<  .05
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the entry of demographic Actors and prior to the entry of the set of psychosocial 
variables. Age and race were selected as demographic variables to be controlled in 
the regression model on the basis of their relations to nonadherence in the descriptive 
analyses. In this analysis, race was dummy coded as Caucasian versus minority and 
medical provider consistency was dummy coded as either doctor changed or not 
changed during the course of the study. The overall hierarchical regression model 
supported the hypothesis that psychosocial factors (hopelessness, religious coping 
behaviors, perceived social support) added significantly to the variabiliQr in medical 
appointment nonadherence accounted for by medical care Actors (length of 
treatment, disease sAtus, physician change), when relevant demogrt̂ hic factors (age, 
race) were controlled for in the first block (R  ̂ = .24, F ( I, 143) =  5.29, p <
.(X)I). Specifcally, age, race, disease sAtus, and perceived social support were 
significantly assocAted with the percent of medical appointmenA no-showed [See 
Table 12]. In block 1, greater nonadherence was associated with younger age 
(P =  -.20, t  — 2.66, p <  .01) and minority sAtus (t =  2.22, p <  .05). In block 2, 
higher t-cell counA (i.e., healthier disease sAtus) were associated with greater 
nonadherence (P =  .16, t =  2.15, p <  .05), but the other medical care Actors did 
not contribute independently to the prediction of nonadherence. In block 3, social 
support was the only significant psychosocial predictor of nonadherence, with higher 
levels of perceived social support associated with lower rates of nonadherence 
(P =  -.19,1 =  2.17, p <  .05).
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To test the second research question, a MANOVA comparing hopelessness, 
social support, and coping at baseline across disease status groups was conducted. 
The multivariate analysis yielded no significant difference in psychosocial measures 
as a function of disease group. Mean hopelessness, social support, and coping scores 
for each disease status group (AIDS, immunocompromised, and HIV-infected) are 
presented in Table 13.
A One-way ANOVA was performed to examine the third research question 
regarding whether appointment nonadherence rates would vary across disease groups. 
Significant difierences in nonadherence at follow-up were found across disease status 
groups, (F (2, 147) =  3.19, p <  .05). Tukey HSD post-hoc comparisons indicated 
that the least ill HIV-infected patients had significantly greater percentage rates of 
appointment no-shows than immunocompromised patients, but were not significantly 
difiërent from the nonadherence rates of AIDS patients. AIDS patients also did not 
significantly differ fiom those in the immunocompromised range. Mean percent 
nonadherence across disease groups is presented in Table 14. Interestingly, 
examination of the percentage data within the context of the appointment frequencies 
presented in Table 15, suggests that these findings are not merely an artifact of 
differing schedule demands across disease groups providing variable opportunities to 
miss appointments.
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Table 11. APPOINTMENT NONADHERENCE FOR ALL SURVIVORS
M m Range
Frequency Appointments No-Showed 1.64 1.61 0 - 8
Frequency Appointments Missed 1.93 1 . 6 6 0 - 8
Percent Appointments No-showed 25.5 2 1 . 1 0-78
Percent Appointments Missed 29.4 2 1 . 2 0-80
Total Appointments Scheduled 6 . 6 3.44 2-23
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Table 12. HIERARCHICAL MULTIPLE REGRESSION PREDICTING 
PERCENTAGE OF NO-SHOWED APPOINTMENTS
Block Variable Multiple R R2 F R̂  Change
1 Age**
Race* .37 .14 11.35***
2 CD4*
Treat Length
MD Change .39 .15 5.01*** . 0 1
3 BHS
WORCS
ISEL* .49 .24 5.29*** .09**
<  .05 N = 144
* *U  <  .01 
<  .001
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Table 13. PSYCHOSOCIAL MEASURES BY DISEASE STATUS GROUPS
CD4  < 2 0 0 CD4  200-500 CD4  >500 N
Mean SD Mean SD Mean SD
BHS 7.32 5.46 5.22 4.80 5.25 4.48 158
ISEL 113.5 25.09 118.5 23.45 121.6 20.13 151
WORCS 81.80 41.93 96.52 29.93 89.51 38.27 156
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Table 14. MEAN PERCENT APPOINTMENT NONADHERENCE BY DISEASE 
STATUS GROUPS
CD4  < 2 0 0 CD* 200-500 CD* >500
Mean SD Mean SD Mean SD
% No-Showed 25.25 20.94 2 2 . 1 0 * 20.06 32.75* 21.99
•'group differences, g<.05
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
64
Table 15. MEAN FREQUENCY APPOINTMENTS BY DISEASE STATUS 
GROUPS
CD4  < 2 0 0 CD4  200-500 CD4  >500
Mean SD Mean SD Mean SD
Total Scheduled 8.33 4.60 5.94 2.73 5.72 2.28
Total No-Showed 2.02 1.96 1.31 1.31 1 . 8 6  1.60
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DISCUSSION
The primary aim of this study was to identify factors predictive of 
nonadherence to outpatient HIV treatment services. Results indicated that age, race, 
disease severity, and perceived social support predicted no-shows at HIV clinic 
appointments. Specifically, greater nonadherence to outpatient appointments was 
associated with younger age, minority background, less severe illness, and lower 
perceived social support. Although demographic characteristics (age, in particular) 
predicted the greatest variance in appointment nonadherence, the hypothesis that 
psychosocial factors (hopelessness, religious coping behaviors, perceived social 
support) and medical care factors (length of treatment, disease status, physician 
consistency) would predict percentage of medical appointment nonadherence, was 
supported even when the most relevant demographic predictors were first statistically 
controlled. Additionally, it was hypothesized that psychosocial Actors would add 
significantly to the variability in nonadherence accounted for by medical care factors. 
This hypothesis was supported by the finding that psychosocial predictors as a block 
contributed about 9% of the variance in nonadherence, after the medical care factors 
had been entered as a block. As a group, medical care factors accounted for less 
than 2% of the variability in nonadherence. Only CD* counts were a significant 
medical care predictor in this model. Of the psychosocial factors, only social 
support was significantly associated with nonadherence. Hypotheses that longer 
duration of medical care, less consistent care, higher levels of hopelessness and
65
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lower levels of religious coping would be associated with greater nonadherence were 
not supported.
Adherence to increasingly effective medical interventions designed to slow 
disease progression is critical for improving the quantity and quality of life of 
individuals infected with HIV. This study was based on the premise that all patients 
must return consistently for medical services in order to benefit from any 
HIV-related prophylactic or therapeutic interventions. Thus, percentage of medical 
appointment nonattendance was conceptualized as a measure of nonadherence which 
is both direct and versatile enough to make comparisons across the HIV/AIDS 
disease spectrum. Overall, participants were found to attend on average about 70% 
of H IV outpatient appointments (excluding those missed due to inpatient care). 
Averaging across the disease spectrum, approximately one of every four 
appointments was a "no-show." That is, about 25% of scheduled appointments were 
neither attended or cancelled in this sample in which patients in the 
immunocompromised range were over represented.
Patients at different phases along the HIV-AIDS disease spectrum are asked to 
adhere to very different treatment regimens. Medical demands vary widely for 
patients who are asymptomatic or those whose treatments must combat a host of 
opportunistic AIDS-related infections. Results indicated that nonadherence, as 
measured by no-show rates, varied according to disease status. Outpatients who 
were not yet in the immunocompromised range (i.e., those most likely to present 
with mild to no symptoms) had significantly more nonadherent appointment keeping
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behavior than HIV-infected patients who were immunocompromised (i.e., those who 
were likely symptomatic, but had not progressed to AIDS). HIV-infected 
outpatients with CD4 counts above 5(X) no-showed on average about one-third of 
scheduled appointments, whereas immtmocompromised patients with CD4 counts 
between 200 and 500 missed less than one in four (22%) of appointments due to no- 
shows. Interestingly, nonadherence among the less ill HTV-infected patients was not 
significantly different from sicker patients in the AIDS stage of the disease, who 
were not adherent to appointments approximately 25% of the time. Further 
investigation is needed to determine the reliability of this pattern and whether such 
differences in appointment attendance have a significant clinical impact. The present 
study is one of several recent studies to clearly demonstrate differences in 
nonadherence across HIV disease severity (Singh et al., 1996), and one of the first to 
find such differences in HIV outpatient appointment-keeping. In a recently published 
pilot study conducted with 46 veterans with HIV or AIDS, Singh and colleagues 
(1996) similarly demonstrated that a history of opportunistic infection prior to entry 
into a prospective study was related to lower rates of medication nonadherence, as 
measured by pharmacy records and laboratory test correlates associated with AZT 
consumption. However, in their sample, no baseline differences in CD  ̂counts were 
found across dichotomous AZT adherence/nonadherence groups.
Nonadherence rates in this cross-sectional portion of the study essentially 
followed the same pattern that psychological distress is widely believed to follow 
(Kalichman, 1995). That is, nonadherence was most pronounced early in the disease
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course, least problematic in the middle of the disease course, and then somewhat 
higher (although not significantly so) when the disease progressed to AIDS.
However, cross-sectional baseline multivariate analyses did not support this 
hypothesized pattern for the psychosocial measures employed in the present study. 
Taken as a group, no significant differences in hopelessness, perceived social 
support, and religious coping were found across disease status groups. One possible 
reason for this finding might be related to the differing demographic makeup of the 
disease status groups. For example, reflecting changing trends in HIV infection 
patterns, the AIDS patients in this sample were more likely than more recently 
infected individuals to be non-drug injecting, homosexual, Caucasian males. As 
significant differences in the psychosocial measures were found across racial, 
orientation, and drug injection groups, it may be that cultural and environmental 
factors played a more important role in psychological adjustment to the disease than 
did the stage of the disease itself.
The finding that younger age is associated with increased medical 
nonadherence is consistent with work in progress in San Francisco (M. Chesney, 
personal communication, March 9, 1997). Some possible explanations for this 
phenomenon might include lack of previous medical contact or perceived 
invulnerability to death among young adults, or differences in lifestyle fiictors such as 
drug use or regularity of daily schedules. Results of the present study suggesting 
that individuals from minority backgrounds and those early in the disease process are 
at high risk for nonadherence are also consistent with other recent investigations
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(McClure, 1996; Muma et al., 1995; Singh et al., 1996). For example, in addition 
to linking disease history to AZT adherence, Singh and colleagues (1996) found that 
African-Americans in their sample had higher rates of nonadherence, independent of 
other demographic factors such as education level or injection drug use.
Psychosocial adjustment was conceptualized in this study as comprised of 
both the absence of distress (e.g., hopelessness) and adequate resources for managing 
disease-related demands (e.g., coping and social support). Earlier HIV research 
suggesting that social support plays an important role in medical nonadherence (e.g., 
Morse et al., 1991; Shelton et al., 1993) appears to be supported by the present 
study. Higher levels of perceived social support were associated with less outpatient 
visit nonadherence. Thus, there seems to be support for the idea that some 
dimensions of adequate psychosocial adjustment may be negatively linked to 
nonadherence. However, recent studies provide equivocal support for baseline levels 
of distress predicting subsequent nonadherence to appointments or medication 
regimens (McClure, 1996; Singh etal., 1996). Baseline levels of hopelessness and 
religious coping were not found to be significant predictors of nonattendance in the 
present study, just as depression and anxieQr were not supported as important factors 
in McClure's (1996) investigation, despite the consistent finding that social support 
has been linked to outpatient nonadherence. So, perhaps it the unitary dimension of 
social support rather than a multi-component "adjustment” construct that is important 
for promoting adherence.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
70
These psychosocial fîndings should be viewed within the context of the 
limitations of the study. Rather than employing a repeated measures design, baseline 
psychosocial data was utilized for the purpose of predicting subsequent nonattendance 
outcomes, as missing data from those who never returned for bloodwork or 
additional psychosocial batteries was thought likely to exclude from representation 
the very research participants of most interest in the prediction model.
Unfortunately, this makes it difRcult to draw Orm conclusions about the importance 
of constructs such as hopelessness, which are based here only on a cross-sectional 
"snapshot” measure of this variable likely to fluctuate over time. Likewise, a good 
deal of the unaccounted for error in the medical care portion of the model may be 
due to measurement issues. For example, consistency of care (i.e., change in 
physician) is a Airly rough index of the complex construct of patient/provider 
relationships. Although it appeared important to include potential sources of 
variability such as mid-study changes in providers, the way in which this variable 
was measured in the present study did not tap into dimensions such as patient 
satisfaction with the initial provider. Although additional subjects were recruited so 
that adequate statistical power for the analysis could be retained when demographic 
variables were included in the regression model, power considerations still limited 
the number of predictor variables which could be investigated in this one study.
Much of the variance in nonadherence remained unaccounted for by the present 
model. Thus, studies extending this line of research should focus on identifying
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additional factors predictive of HIV-related outpatient nonadherence, such as patient 
satisAction with care or trait variables such as health locus of control.
Research in the area of H IV nonadherence is at an early stage of theory 
development, and the present study should be viewed as just one attempt to elucidate 
possible Actors for future inclusion in a broad model of HIV-related nonadherence. 
Management of HIV is a r^id ly changing area, and new medical developments must 
constantly be incorporated into the psychosocial research in this field. Just as data 
collection was being completed for the present study, a new class of medications 
called protease inhibitors were approved by the FDA. Combination medication 
therapies including protease inhibitors have quickly become the standard of care 
because such interventions have been demonstrated to dramatically reduce the rate of 
viral reproduction, even to the point that viral load in the blood may be undetectable 
and immunological decline is slowed or temporarily reversed (Fauci, 1996; 
Marchland et al., 1996). Unfortunately, the newest treatment regimens are 
extremely complex and difficult to tolerate. For example, nausea may be 
pronounced when therapy is initiated, and the regimens require strict adherence to 
taking multiple medications at frequent dose intervals carefully coordinated with 
meals. Not only do these regimens require a lifestyle level of behavioral change to 
be efficacious, but poor adherence leads quickly to the development of drug resistant 
strains of HIV. As cross-resistance occurs across the class of protease inhibitor 
drugs, a nonadherent patient could effectively cut him/herself off from the best 
medical means of slowing disease progression by failing to take these medications as
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prescribed. Nonadherence to HIV-related treatments have thus taken on a new level 
of importance in the past year. In the context of outpatient appointment 
nonadherence, those who do not attend appointments regularly enough to receive the 
best available medical care now are unlikely to benefit from the improvements in 
quality and length of life which these treatments offer. From a public health 
standpoint, it may also be critical to identify whether predictors of nonadherence to 
combination medication regimens are the same Actors involved in nonadherence to 
safer sexual and drug injection behavioral changes. It is conceivable that the very 
individuals likely to develop resistant strains of the virus due to nonadherence will be 
the same individuals infecting others at the highest rates.
Clearly, future research must focus on identifying individuals most at risk for 
nonadherence. The fîeld will also need to draw upon the general noncompliance 
literature to develop interventions to promote adherence as rapidly as possible.
There are a number of other unanswered questions about adherence raised by these 
newest medical advances. For example, will the complexity of the regimens 
overshadow the importance of psychosocial influences on nonadherence, or will the 
increasing difficulty of medical demands make tangible and informational types of 
social support (i.e ., reminders to take medication; understanding of instructions), 
self-efficacy (i.e ., belief in one's ability to carry out the necessary health behaviors), 
or learning history (i.e., time management behaviors; past medical care 
reinforcement contingencies) become much more important factors in promoting 
adherence? The current investigation of outpatient nonadherence, while not designed
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to address these emerging questions, does at least provide some clues about the type 
of variables which should be included in future exploration of medication 
nonadherence. The results o f this study suggest that a special focus on investigating 
nonadherence among younger patients, those from minority backgrounds, individuals 
with mild or no physical symptoms, and those reporting limited social support 
resources may be warranted.
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SUMMARY
In summary, nonadherence to medical regimens has become a critical 
behavioral threat to the health of HIV-infected individuals. Patients cannot benefit 
optimally from increasingly efRcacious treatments for HIV/AIDs if they do not 
adhere to their recommended regimens. Medical management of this chronic, life- 
threatening syndrome entails regular medical monitoring and ongoing preventive and 
curative interventions. Consistent medical care plays a key role in prolonging life, 
improving general health, and enhancing overall qualî  of life among individuals at 
each phase of the HTV/AIDS spectrum. Nonadherence to HIV-related medical 
regimens therefore presents a very serious health issue (Chesney & Folkman, 1994). 
At the time the present study was undertaken, few empirical studies had investigated 
the magnitude of this problem or carefully explored biopsychosocial factors likely to 
contribute to medical nonadherence in this population. Thus, this study attempted to 
identify factors predictive of HIV-related outpatient nonadherence. Only by 
developing a broad etiological model of HIV nonadherence are specific interventions 
promoting improved adherence likely to be effective.
Percentage of medical appointment nonattendance was conceptualized as a 
measure of nonadherence which was both direct and comprehensive enough to make 
comparisons across the disease spectrum and diverse treatments regimens. 
Nonadherence was demonstrated to be most pronounced early in the disease course, 
least problematic in the middle of the disease course, and then somewhat higher 
when the disease progressed to AIDS. Demographic, medical care, and psychosocial
74
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factors were identified that prospectiveiy predicted percentage of scheduled HIV- 
related appointments no-showed by outpatients. Specifically, greater nonadherence to 
outpatient appointments was associated with younger age, minority background, less 
severe illness, and lower perceived social support. Individuals from minority 
backgrounds and younger cohorts are at high risk for nonadherence H IV  treatment 
demands. Those early in the disease process may also be at some risk for higher 
rates of nonadherence. Particularly important from an intervention standpoint, 
higher levels of perceived social support were clearly associated with less outpatient 
visit nonadherence. This study represents an attempt to begin building a predictive 
model upon which a more comprehensive theory of HIV nonadherence can grow. 
Hopefully, future models will lead to effective interventions addressing current 
barriers to H IV medication adherence.
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APPENDIX 
INFORMED CONSENT 
LOUISIANA STATE UNIVERSITY MEDICAL CENTER IN  NEW ORLEANS
CONSENT FORM
1. Study Title: The impact of stress, mood, and social support on HIV 
disease status.
2. Perlbnnamce Site: Early Intervention Clinic at Earl K. Long Medical Center, 
Baton Rouge, Louisiana.
3. Names and Telephone Numbers of investigators:
For 24-hour access, please call: (504)358-1105
PhUlip J. BranUey, Ph.D. (504)358-1105
Glenn N. Jones, Ph.D. (504)358-1429
Jennifer B. McClure (504)358-1105
Sheryl L. Catz (504)358-3927
4. Purpose of the Study: This is a research study designed to investigate how 
stress, mood, social support, and general ways of coping impact the health status of 
patients with HIV. Aside from participating in a brief psychological/medical history 
and filling out questionnaires (e.g. on stress, H IV symptoms, mood, social support, 
and coping) approximately every three to six months, research subjects will not be 
treated any differently than other patients at the clinic. The laboratory analysis of 
immune functioning is part of the medical assessment that all patients undergo 
routinely.
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5. Subject Inclusion Criteria: Individuals between the ages of 18 and 65 are 
eligible to participate in the study. Participants must be H IV positive.
6. Subject Exclusion Criteria: Individuals will not be eligible to participate in the 
study if they are unable to read or comprehend the nature of the questionnaires for 
any reason (e.g., illiteracy).
7. Description of the Study: During a routine clinic appointment, when laboratory 
analysis of immune functioning has been scheduled, patients at the clinics will be 
informed of the study by a attending nurse or physician. If  a patient volunteers to 
participate, he/she will sign the informed consent. A graduate student in clinical 
psychology at Louisiana State Universî  will conduct an interview to gather a brief 
medical and psychological history. Subject then will complete questionnaires (e.g. 
on stressful life events, social support, mood, coping, and HIV symptoms). Subjects 
allow the experimenter access to their medical records to obtain laboratory reports 
and other medical information (e.g., medication usage, onset of symptoms, number 
of visits to the clinic). At or before regularly scheduled follow-up clinic 
appointments, participants will be reminded of the project and again asked to 
complete the questionnaires.
8. Benefits to Subject: Subjects will receive $5.00 following each participation in 
the study. Other potential benefits may include increased knowledge about HIV and 
strategies to cope with the disease.
9. Risks to Subject: There are no known major physical, psychological, or social 
risks associated with participation in this study. However, there may be unforeseen
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risks associated with participation. Lesser risks can be explained if the subjects 
desire this information. Subjects should not expect their medical conditions to 
improve by participation in this study. If  the subjects wish, the experimenter can 
provide a referral for additional assistance.
10. Attematives to Partidpatioa in the Study: Participation is voluntary. Subjects 
who choose not to participate will attend their clinic as usual.
11. Subject Removal: There are no foreseeable circumstances under which eligible 
subjects would be removed from the study against their wishes.
12. Subject's Right to Refuse to Participate or Withdraw: Study subjects may 
refuse to participate or withdraw from the study at any time without jeopardizing, in 
any way, their medical treatment at this institution in the present or the future. 
Should significant new Andings develop during the course of the research which may 
relate to the subject's willingness to continue participation, that information will be 
provided to the subject.
13. Subjects Right to Privacy: The results of the study may be published, released 
to a funding agency or presented in a scholarly fashion (e.g., at a conference). The 
privacy and confidentiality of subjects will be protected, and they will not be 
identified in any way.
14. Release of information: The medical records related to the study are available 
to the experimenter. By agreeing to participate in this research study and by signing 
the consent form, the subject gives permission for his/her attending medical staff to
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release relevant medical infonnation(e.g., diagnoses, medications, rate of clinic 
attendance) to the experimenter.
15. Financial Information:
A. Participation in this study will not result in any extra charges above and 
beyond those routinely incurred by patients with similar illnesses.
B. The costs of the study related to unforeseen complications must be met 
by subjects.
C. Subject payment: Subjects will be paid $5.00 for participation in 
the study.
16. Signatures: The study has been discussed with me and all my questions have 
been answered. I understand that additional questions regarding the study should be 
directed to investigators listed on page one of this consent form. I understand that if 
I have questions about subjects rights, or other concerns, I can contact Dr. Perry G. 
Rigby, Chancellor, at (504)568-4801. I agree with the terms above and acknowledge 
1 have been given a copy of the consent form.
Signature of Subject Date
Signature of Witness Date
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